価格表

在庫・価格 : 2024年05月07日 07時37分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-IgA(α), Rat, Goat-Poly, HRP
データシート
A110-102P BETベチル ラボラトリーズ
Bethyl Laboratories, Inc.
1 mg ¥39,000
(未発注)
追加

在庫・価格 : 2024年05月07日 07時37分 現在

Anti-IgA(α), Rat, Goat-Poly, HRP

  • 商品コード:A110-102P
  • メーカー:BET
  • 包装:1mg
  • 価格: ¥39,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Bondy G et al. Toxicity of trans-nonachlor to Sprague-Dawley rats in a 90-day feeding study. Food Chem. Toxicol. 2004 Jun;42(6):1015-27
Bondy G et al
2004/01/01
PubMed
2 Sabirov A et al. Intranasal immunization with outer membrane protein P6 and cholera toxin induces specific sinus mucosal immunity and enhances sinus clearance of nontypeable Haemophilus influenzae. Vaccine 2004 Aug;22(23-24):3112-21
Sabirov A et al
2004/01/01
PubMed
3 Huang J et al. A novel dry powder influenza vaccine and intranasal delivery technology: induction of systemic and mucosal immune responses in rats. Vaccine 2004 Dec;23(6):794-801
Huang J et al
2004/01/01
PubMed
4 Novotny LA et al. Transcutaneous immunization as preventative and therapeutic regimens to protect against experimental otitis media due to nontypeable Haemophilus influenzae. Mucosal Immunol 2011 Jul;4(4):456-67
Novotny LA et al
2011/01/01
PubMed
5 Novotny LA et al. Kinetic analysis and evaluation of the mechanisms involved in the resolution of experimental nontypeable Haemophilus influenzae-induced otitis media after transcutaneous immunization. Vaccine 2012 Oct;
Novotny LA et al
2012/01/01
PubMed
6 Buchanan RM et al. Low dose antigen exposure for a finite period in newborn rats prevents induction of mucosal tolerance. PLoS ONE 2012;7(12):e51437
Buchanan RM et al
2012/01/01
Applications: ELISA PubMed
7 Shaffer TL et al. Use of the Chinchilla model to evaluate the vaccinogenic potential of the Moraxella catarrhalis filamentous hemagglutinin-like proteins MhaB1 and MhaB2. PLoS ONE 2013;8(7):e67881
Shaffer TL et al
2013/01/01
PubMed
  • No.: 1
  • 文献情報:
    Bondy G et al. Toxicity of trans-nonachlor to Sprague-Dawley rats in a 90-day feeding study. Food Chem. Toxicol. 2004 Jun;42(6):1015-27
    Bondy G et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Sabirov A et al. Intranasal immunization with outer membrane protein P6 and cholera toxin induces specific sinus mucosal immunity and enhances sinus clearance of nontypeable Haemophilus influenzae. Vaccine 2004 Aug;22(23-24):3112-21
    Sabirov A et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Huang J et al. A novel dry powder influenza vaccine and intranasal delivery technology: induction of systemic and mucosal immune responses in rats. Vaccine 2004 Dec;23(6):794-801
    Huang J et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Novotny LA et al. Transcutaneous immunization as preventative and therapeutic regimens to protect against experimental otitis media due to nontypeable Haemophilus influenzae. Mucosal Immunol 2011 Jul;4(4):456-67
    Novotny LA et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Novotny LA et al. Kinetic analysis and evaluation of the mechanisms involved in the resolution of experimental nontypeable Haemophilus influenzae-induced otitis media after transcutaneous immunization. Vaccine 2012 Oct;
    Novotny LA et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Buchanan RM et al. Low dose antigen exposure for a finite period in newborn rats prevents induction of mucosal tolerance. PLoS ONE 2012;7(12):e51437
    Buchanan RM et al
    2012/01/01
  • 備考:
    Applications: ELISA
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Shaffer TL et al. Use of the Chinchilla model to evaluate the vaccinogenic potential of the Moraxella catarrhalis filamentous hemagglutinin-like proteins MhaB1 and MhaB2. PLoS ONE 2013;8(7):e67881
    Shaffer TL et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed